This stable binding mode suggests that the observed anti-pancreatic cancer activity of C. colocynthis extract is attributed to EGFR inhibition by Cucurbita-5(10),6,23-triene-3β,25-diol. Here, EGFR is linked to familial pancreatic carcinoma.